TVM Capital Healthcare Partners, a Dubai-based private equity business, has launched a $250 million fund to invest in areas ranging from cancer to pharmaceuticals in markets including the Gulf, Turkey, Egypt, India and Singapore, a senior executive told Reuters. The company plans to make the investments over the next two years, with the first deal scheduled to close in the second half of 2018, said Charles Floe, operating partner. TVM Capital Healthcare has targeted markets it thinks offer accelerated growth in healthcare development and spending, underpinned by some of the fastest growing economies.